<?xml version="1.0"?>
<case>
<name>Visible Results Properties Inc v Sushi Train (Australia) Pty Limited (Corrigendum dated 11 April 2007) [2007] FCA 38 (7 February 2007)</name>
<AustLII>http://www.austlii.edu.au/au/cases/cth/FCA/2007/38.html</AustLII>
<citphrases>
<citphrase id="cp0.0" type=cited from="[2006] FCAFC 91">patents</citphrase>
<citphrase id="cp0.1" type=cited from="[2006] FCAFC 91">bisphosphonates known to inhibit bone resorption</citphrase>
<citphrase id="cp0.2" type=cited from="[2006] FCAFC 91">oral administration of bisphosphonates known to cause gastrointestinal side effects</citphrase>
<citphrase id="cp0.3" type=cited from="[2006] FCAFC 91">administration of bisphosphonates at high relative dosage and low relative dosing frequency found to reduce side effects  patents</citphrase>
<citphrase id="cp0.4" type=cited from="[2006] FCAFC 91">manner of manufacture</citphrase>
<citphrase id="cp0.5" type=cited from="[2006] FCAFC 91">new dosage regime for known substance to treat known condition</citphrase>
<citphrase id="cp0.6" type=cited from="[2006] FCAFC 91">high dosage weekly as opposed to regimens of low dosage daily or cyclic treatments patents</citphrase>
<citphrase id="cp0.7" type=cited from="[2006] FCAFC 91">novelty</citphrase>
<citphrase id="cp0.8" type=cited from="[2006] FCAFC 91">industry journal distributed via mailing list</citphrase>
<citphrase id="cp0.9" type=cited from="[2006] FCAFC 91">whether to be 'publicly available' a publication must be catalogued or identified in a way which would enable anybody to find it</citphrase>
<citphrase id="cp0.10" type=cited from="[2006] FCAFC 91">articles suggest dosage regime 'needs to be tested'</citphrase>
<citphrase id="cp0.11" type=cited from="[2006] FCAFC 91">whether articles nonetheless constitute an anticipation</citphrase>
<citphrase id="cp1.0" type=cited from="[2005] FCAFC 224">patents</citphrase>
<citphrase id="cp1.1" type=cited from="[2005] FCAFC 224">validity</citphrase>
<citphrase id="cp1.2" type=cited from="[2005] FCAFC 224">construction</citphrase>
<citphrase id="cp1.3" type=cited from="[2005] FCAFC 224">lack of inventive step</citphrase>
<citphrase id="cp1.4" type=cited from="[2005] FCAFC 224">novelty</citphrase>
<citphrase id="cp1.5" type=cited from="[2005] FCAFC 224">fair basis</citphrase>
<citphrase id="cp1.6" type=cited from="[2005] FCAFC 224">sufficiency of description of invention</citphrase>
<citphrase id="cp1.7" type=cited from="[2005] FCAFC 224">disclosure of best method of invention</citphrase>
<citphrase id="cp1.8" type=cited from="[2005] FCAFC 224">date of assessment</citphrase>
<citphrase id="cp1.9" type=cited from="[2005] FCAFC 224">false suggestion</citphrase>
<citphrase id="cp1.10" type=cited from="[2005] FCAFC 224">patent for treatment of erectile dysfunction</citphrase>
<citphrase id="cp1.11" type=cited from="[2005] FCAFC 224">common general knowledge at priority date</citphrase>
<citphrase id="cp1.12" type=cited from="[2005] FCAFC 224">relevant prior art</citphrase>
<citphrase id="cp1.13" type=cited from="[2005] FCAFC 224">use of evidence of overseas witnesses</citphrase>
<citphrase id="cp2.0" type=cited from="[2005] FCAFC 220">198 the basis of the primary judge's decision was that there was no s 117 issue to be determined</citphrase>
<citphrase id="cp2.1" type=cited from="[2005] FCAFC 220">all relevant admissions had been made. that is, the effect of fresenius' admissions and conduct led gambro to conclude, properly, that there was no suggestion that s 117 would not apply. whether the issue that fresenius sought to raise after delivery of the first decision, and now seeks to reagitate, was factual or legal, gambro's contention was that, had it known that there was such an issue, it would have run a case on authorisation. his honour accepted that contention. it follows that, even if the matters now sought to be raised are questions of law, the fact remains that, had gambro been aware that fresenius intended to raise an issue about the application of s 117, it would have run a different case. the primary judge thought that was a conclusive consideration. we see no error in his approach.</citphrase>
<citphrase id="cp3.0" type=cited from="[2005] FCA 788">patent</citphrase>
<citphrase id="cp3.1" type=cited from="[2005] FCA 788">infringement</citphrase>
<citphrase id="cp3.2" type=cited from="[2005] FCA 788">mechanical combination</citphrase>
<citphrase id="cp3.3" type=cited from="[2005] FCA 788">principles of claim construction</citphrase>
<citphrase id="cp3.4" type=cited from="[2005] FCA 788">evidence on technical and non-technical terms</citphrase>
<citphrase id="cp3.5" type=cited from="[2005] FCA 788">evidence on working of the embodiments</citphrase>
<citphrase id="cp3.6" type=cited from="[2005] FCA 788">relevance of description to construction of claim</citphrase>
<citphrase id="cp3.7" type=cited from="[2005] FCA 788">principles of infringement</citphrase>
<citphrase id="cp3.8" type=cited from="[2005] FCA 788">relevance of purposive construction</citphrase>
<citphrase id="cp3.9" type=cited from="[2005] FCA 788">catnic</citphrase>
<citphrase id="cp3.10" type=cited from="[2005] FCA 788">improver questions</citphrase>
<citphrase id="cp3.11" type=cited from="[2005] FCA 788">relevance of protocol questions</citphrase>
<citphrase id="cp3.12" type=cited from="[2005] FCA 788">it is not infringement to take substantial idea but not essential integers</citphrase>
<citphrase id="cp3.13" type=cited from="[2005] FCA 788">meaning of "pith and marrow"</citphrase>
<citphrase id="cp3.14" type=cited from="[2005] FCA 788">preferred embodiment not within claim 1</citphrase>
<citphrase id="cp3.15" type=cited from="[2005] FCA 788">claim not necessarily coexistent with inventive step</citphrase>
<citphrase id="cp3.16" type=cited from="[2005] FCA 788">limitation by result</citphrase>
<citphrase id="cp3.17" type=cited from="[2005] FCA 788">no infringement</citphrase>
<citphrase id="cp4.0" type=cited from="[2005] FCAFC 90">date of hearing: 2</citphrase>
<citphrase id="cp4.1" type=cited from="[2005] FCAFC 90">3 march 2005 date of judgment: 23 may 2005"</citphrase>
<citphrase id="cp5.0" type=cited from="[2004] FCA 1658">patents</citphrase>
<citphrase id="cp5.1" type=cited from="[2004] FCA 1658">novelty</citphrase>
<citphrase id="cp5.2" type=cited from="[2004] FCA 1658">anticipation of specific chemical compound in an earlier broad claim</citphrase>
<citphrase id="cp5.3" type=cited from="[2004] FCA 1658">distinction between a general disclosure and a disclosure for novelty purposes</citphrase>
<citphrase id="cp5.4" type=cited from="[2004] FCA 1658">application by third party to appear amicus curiae in an appeal from delegate of commissioner of patents</citphrase>
<citphrase id="cp5.5" type=cited from="[2004] FCA 1658">refused</citphrase>
<citphrase id="cp5.6" type=cited from="[2004] FCA 1658">applicant's appeal allowed.</citphrase>
<citphrase id="cp9.0" type=cited from="[1977] HCA 19">patent</citphrase>
<citphrase id="cp9.1" type=cited from="[1977] HCA 19">infringement</citphrase>
<citphrase id="cp9.2" type=cited from="[1977] HCA 19">counterclaim for revocation</citphrase>
<citphrase id="cp9.3" type=cited from="[1977] HCA 19">novelty</citphrase>
<citphrase id="cp9.4" type=cited from="[1977] HCA 19">prior user</citphrase>
<citphrase id="cp9.5" type=cited from="[1977] HCA 19">prior publication</citphrase>
<citphrase id="cp9.6" type=cited from="[1977] HCA 19">obviousness</citphrase>
<citphrase id="cp9.7" type=cited from="[1977] HCA 19">patents act 1952 (cth), s. 100 (1) (e), (g).</citphrase>
<citphrase id="cp10.0" type=citing from="[2007] FMCA 824">migration</citphrase>
<citphrase id="cp10.1" type=citing from="[2007] FMCA 824">bias rarely demonstrated from published decision</citphrase>
<citphrase id="cp10.2" type=citing from="[2007] FMCA 824">test for apprehended bias</citphrase>
<citphrase id="cp10.3" type=citing from="[2007] FMCA 824">bring an impartial mind to the resolution of the question</citphrase>
<citphrase id="cp10.4" type=citing from="[2007] FMCA 824">applicant invited to attend hearing</citphrase>
<citphrase id="cp10.5" type=citing from="[2007] FMCA 824">failed to attend</citphrase>
<citphrase id="cp10.6" type=citing from="[2007] FMCA 824">failure to provide sufficient information to prove case is a valid reason for rejection</citphrase>
<citphrase id="cp10.7" type=citing from="[2007] FMCA 824">s.424a</citphrase>
<citphrase id="cp10.8" type=citing from="[2007] FMCA 824">thought processes not "information".</citphrase>
</citphrases>
<citances>
<sentence id="cs0" from="[2007] FMCA 824">When the applicant failed to attend to accept that opportunity the inevitable consequence was the rejection of the application: SZIGQ v Minister for Immigration and Citizenship [2007] FCA 38 per Downes J at para 5.</sentence>
</citances>
<legistitles>
<title id="l0">PATENTS ACT 1990 </title>
<title id="l1">FEDERAL COURT RULES </title>
</legistitles>
</case>